Core Laboratories Inc. /DE/ Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Core Laboratories Inc. /DE/ quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2022 to Q4 2023.
  • Core Laboratories Inc. /DE/ Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2023 was $7.81M, a 40.3% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $7.81M -$5.28M -40.3% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $13.1M Dec 31, 2022 10-K 2024-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.